Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Makris, C. Articles by Karin, M. Search for Related Content PubMed PubMed Citation Articles by Makris, C. Articles by Karin, M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2002, p. 6573-6581, Vol. 22, No. 18
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.18.6573-6581.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

The Carboxyl-Terminal Region of IB Kinase (IKK) Is Required for Full IKK Activation

Constantin Makris,^1, Jaclyn L. Roberts,² and Michael Karin^1*

Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California, San Diego, La Jolla, California 92093-0636,¹ Department of Obstetrics and Gynecology, State University of New York Health Science Center, Brooklyn, New York 11203²

Received 18 March 2002/ Returned for modification 24 April 2002/ Accepted 4 June 2002

Top Abstract Introduction Materials and Methods Results Discussion References

 
IB kinase (IKK) (also known as NEMO, Fip-3, and IKKAP-1) is the essential regulatory component of the IKK complex; it is required for NF-B activation by various stimuli, including tumor necrosis factor alpha (TNF-), interleukin 1 (IL-1), phorbol esters, lipopolysaccharides, and double-stranded RNA. IKK is encoded by an X-linked gene, deficiencies in which may result in two human genetic disorders, incontinentia pigmenti (IP) and hypohidrotic ectodermal dysplasia with severe immunodeficiency. Subsequent to the linkage of IKK deficiency to IP, we biochemically characterized the effects of a mutation occurring in an IP-affected family on IKK activity and NF-B signaling. This particular mutation results in premature termination, such that the variant IKK protein lacks its putative C-terminal Zn finger and, due to decreased mRNA stability, is underexpressed. Correspondingly, IKK and NF-B activation by TNF- and, to a lesser extent, IL-1 are reduced. Mutagenesis of the C-terminal region of IKK was performed in an attempt to define the role of the putative Zn finger and other potential functional motifs in this region. The mutants were expressed in IKK-deficient murine embryonic fibroblasts (MEFs) at levels comparable to those of endogenous IKK in wild-type MEFs and were able to associate with IKK and IKKß. Substitution of two leucines within a C-terminal leucine zipper motif markedly reduced IKK activation by TNF- and IL-1. Another point mutation resulting in a cysteine-to-serine substitution within the putative Zn finger motif affected IKK activation by TNF- but not by IL-1. These results may explain why cells that express these or similar mutant alleles are sensitive to TNF--induced apoptosis despite being able to activate NF-B in response to other stimuli.

Top Abstract Introduction Materials and Methods Results Discussion References

 
The IB kinase (IKK) complex, composed of the IKK and IKKß catalytic subunits (5, 20, 24, 38) and the IKK (NEMO) regulatory subunit (27, 37), is the key to activation of the NF-B/Rel family of transcription factors (12, 26). NF-B dimers are found mainly in the cytoplasm of resting cells in a complex with specific inhibitors, the IB proteins (26). Upon activation, NF-B dimers enter the nucleus in response to stimuli, such as viral and bacterial infections, phorbol esters, antigens, and the proinflammatory cytokines tumor necrosis factor alpha (TNF-) and interleukin 1 (IL-1) (26). NF-B regulates important target genes encoding chemokines, cytokines, adhesion molecules, and even its own inhibitors, IB and IBß. Furthermore, NF-B activation is required for preventing TNF--induced cell death (1, 16, 35, 36). Extracellular stimuli initiate signaling cascades, which lead to the phosphorylation of both IKK and IKKß catalytic subunits (4). Once activated, IKK phosphorylates the IB proteins at specific N-terminal residues (serines 32 and 36 for human IB) and thereby targets them for ubiquitination-dependent proteolysis (12).

Gene targeting in mice revealed that IKKß is essential for IKK and NF-B activation by proinflammatory cytokines and for preventing TNF--induced cell death. Like RelA^-/- mice, which lack the p65 subunit of NF-B (2), Ikkß^-/- mice die at midgestation due to TNF--induced liver apoptosis (14, 15, 33). IKK, however, is neither required nor sufficient for NF-B activation in response to TNF- or other proinflammatory stimuli. Instead, it is required for proper development and differentiation of the epidermis and its appendices (8, 13, 32). This function of IKK, which cannot be provided by IKKß, is not dependent on NF-B activation or the kinase activity of IKK (9). Recently, however, two new functions of IKK which do depend on its kinase activity were identified. First, IKK is required for IB degradation and NF-B activation in mammary epithelial cells in response to a member of the TNF cytokine family called RANK ligand (3). Second, IKK is required for activation of p52-containing NF-B dimers through a mechanism that is independent of IB degradation but is dependent on the processing of the NF-B2 p100 precursor polypeptide to the mature p52 subunit (30).

IKK was identified by two independent approaches. Genetic complementation of cells that were unable to activate NF-B and therefore were extremely sensitive to apoptosis resulted in the isolation of the IKK (NEMO) cDNA (37). Simultaneously, extensive purification of the IKK complex resulted in the isolation of several polypeptides that were clearly distinct from the previously identified IKK and IKKß subunits (27). IKK has several distinct structural motifs, including two coiled-coil regions that are separated by helices, a leucine zipper (LZ) motif, and a putative Zn finger at the extreme C terminus (26). The region responsible for the interaction with IKK and IKKß lies between residues 44 and 86 in the N-terminal domain of IKK (18). It is still not clear how the single Ikk locus gives rise to multiple gene products. Although IKK lacks catalytic functions, it is essential for NF-B activation (17, 28, 29, 37). Cells that lack IKK contain only low-molecular-weight IKK complexes (37), which most likely correspond to IKK and IKKß homo- and heterodimers (38). In addition to the assembly of high-molecular-weight IKK complexes, which seem to contain four catalytic subunits (21), IKK is also required for IKK activation by a variety of stimuli (27). This regulatory function was revealed through the generation of a C-terminal truncation mutant of IKK that, despite being able to assemble high-molecular-weight IKK complexes, failed to support IKK activation (27).

Genetic studies were used to further investigate the physiological role of IKK in regulating NF-B activation in vivo (17, 28, 29). Both the human and the mouse IKK/Ikk loci are located on the X chromosome. Consistent with this chromosomal location, disruption of the Ikk gene in the mouse results in the death of male hemizygous embryos due to severe liver apoptosis similar to that exhibited by Ikkß^-/- or RelA^-/- mice (17, 28). Interestingly, Ikk^+/- females, which are born alive, display a severe but self-limiting inflammatory skin disorder which was shown to be identical to a human X-linked genetic disorder known as incontinentia pigmenti (IP) (17, 29). Indeed, mutations in the human IKK locus were shown to be responsible for IP (31). Recently, other mutations in the IKK locus which, unlike the IP mutations, do not severely reduce NF-B activation, were shown to underlie an X-linked immunodeficiency syndrome called hypohidrotic ectodermal dysplasia with severe immunodeficiency (EDA-ID) (6, 10, 39). Unlike IP, which mostly affects female carriers (the males that inherit the mutant allele die during gestation), EDA-ID mostly affects males, probably because heterozygous females do not experience a considerable NF-B deficiency. It was previously proposed, based on an analysis of Ikk^+/- mice, that a severe NF-B deficiency, which sensitizes cells that express the mutant allele to TNF--induced apoptosis, is essential for the genesis of IP (17).

Although IKK is the only subunit absolutely essential for activation of the IKK complex by diverse stimuli, very little is known about its mechanism of action. It was shown that an amino-terminal -helical region of IKK associates with the carboxyl-terminal segment of either IKK or IKKß and thereby promotes the assembly of the high-molecular-weight IKK complex (18, 23). However, it is not clear which features within the C-terminal region of IKK, which is required for full activation by proinflammatory cytokines but not for complex assembly, mediate its function (27). Interestingly, most of the mutations in IP, as well as EDA-ID, which do not prevent the expression of the IKK polypeptide are located within its C-terminal region (6, 10, 31, 39). Here we describe an IP-linked frameshift mutation that removes completely the putative Zn finger from IKK. The resulting variant IKK polypeptide supports reduced IKK and NF-B activation by either TNF- or IL-1. To further characterize the function of the IKK C-terminal region, we generated several point mutations within the LZ, a putative SH3 binding motif, and the Zn finger. We found that amino acid substitutions within the LZ result in a substantial reduction of IKK activation by both TNF- and IL-1, whereas an amino acid substitution within the Zn finger severely affects IKK activation by TNF- but not IL-1. Cells that express IKK mutants that no longer respond to TNF- are hypersensitive to TNF--induced apoptosis. These results suggest that the C-terminal region of IKK may contain distinct functional motifs required for connecting IKK to different upstream activators.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Plasmid construction and site-directed mutagenesis. The PCM-hygro-IKK (murine) expression vector was provided by A. Israël (Institut Pasteur, Paris, France). The full-length coding sequence of murine IKK was amplified by PCR. BamHI and XhoI sites were introduced into the 5' and 3' ends, respectively. The cDNA fragment was then subcloned into the pBabePuro retroviral vector carrying the puromycin resistance gene. All subcloning and mutagenesis steps were done by using a QuickChange kit (Stratagene, La Jolla, Calif.) as recommended by the manufacturer. A full description of the PCR primers used to generate the different mutants will be provided upon request.

Cell culturing, transfection, and retroviral infection. Wild-type (WT) and IP primary human embryonic fibroblasts (17) were maintained in Chang medium D (Irvine Scientific, Santa Ana, Calif.). WT and IKK-deficient mouse embryonic fibroblasts (MEFs) were described previously (17). MEFs and 293T cells were grown in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, L-glutamine (2 mM; Life Technologies), penicillin (1,000 U/ml), and streptomycin (1,000 µg/ml). Viral stocks were produced by transfecting 2 x 10⁶ 293T cells per 60-mm dish with 2 µg of pBabePuro IKK constructs and 2 µg of the pCLECO vector (22). Supernatants containing fully packaged retrovirus were recovered 48 h after transfection and were immediately used for infection or stored at -80°C. Infection was achieved by incubating IKK-deficient MEFs with 500 µl of viral stock in the presence of Polybrene (8 µg/ml). At 6 h after infection, supernatants were removed and the cells were cultured for an additional 32 h in complete medium. Infected cells were selected with puromycin (2 µg/ml), and individual populations expressing each construct were isolated after about 10 days. The sensitivities of parental and reconstituted Ikk fibroblasts expressing different IKK constructs as well as WT and IP human fibroblasts to TNF--induced apoptosis were examined as described previously (17). Apoptotic nuclei were scored by counting at least 100 cells in five random fields for each experimental condition. Each experiment was done in duplicate.

Immunoprecipitation, kinase, and immunoblot assays and EMSAs. Mouse fibroblasts expressing different IKK constructs as well as WT and IP human fibroblasts were treated or not treated with TNF- (10 ng/ml) or IL-1 (10 ng/ml). At various times, the IKK complex was immunoprecipitated from cell lysates with an anti-IKK monoclonal antibody (MAb) (c73-764; Pharmingen), and activity was measured by an immunocomplex kinase assay with glutathione S-transferase-IB(1-54) as a substrate (27). Gel loading was normalized by immunoblotting with an anti-IKK MAb (IMG-136; 1:500; Imgenex). Immunoblot analysis was done as previously described (8). Electrophoretic mobility shift assays (EMSAs) were performed as described previously (27). Briefly, 10 µg of whole-cell extracts was incubated with 2 µg of poly(dI-dC) and 5,000 cpm of labeled oligonucleotide probes. After 30 min of incubation, samples were resolved on native 5% polyacrylamide gels.

Genomic DNA isolation and CSGE. Peripheral blood samples from an IP-affected patient and her unaffected son were obtained; together with male fibroblasts from the same family that expressed either WT or IP IKK alleles, these samples were used for the extraction of genomic DNA with a Qiagen Genomic-tip system as instructed by the manufacturer. PCR amplification was performed with 100 ng of genomic DNA and primers for individual IKK exons as previously reported (31). Conformation-sensitive gel electrophoresis (CSGE) was performed as described previously (7), with the exception that samples were run on 15% acrylamide gels.

Gel filtration analysis. Lysates from unstimulated WT and IP human embryonic fibroblasts were chromatographed on a Superose 6 gel filtration column as described previously (5). The level of expression and the position of elution of the different IKK subunits were determined after immunoblotting.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Identification of an IKK exon 10 mutation in an IP-affected family. IKK is an X-linked gene in humans and mice (11, 17, 28, 29). Several IKK mutations that result in IP in heterozygous females have been described (31). Based on similarities to the phenotype of Ikk^+/- female mice, it was postulated that the IP mutations result in a severe loss of function in cells that express the mutant allele after X chromosome inactivation (17). However, hypomorphic mutations in IKK that result in reduced NF-B activation in surviving males with EAD-ID have been described (6, 10, 39). We and Roberts et al. previously studied human fibroblasts derived from either unaffected (WT) or stillborn male progeny of an IP-affected mother within an IP-affected family that has been monitored for three generations (Fig. 1A) (17, 25). To molecularly define the mutation in this family, we amplified all coding and noncoding IKK exons (Fig. 1B) and performed CSGE to detect mismatches in DNA heteroduplexes that contain one WT strand and one strand of mutant DNA. We detected two bands for the exon 10 PCR product derived from the IP-affected mother (data not shown). Sequencing of this PCR product revealed a 13-bp duplication following a cytosine tract (Fig. 1C). This duplication results in the addition of four novel amino acids and a premature stop codon after proline 393 (Fig. 1C). These changes result in the complete removal of the putative Zn finger at the extreme C terminus of IKK (Fig. 1D).

View larger version (17K): [in this window] [in a new window]

FIG. 1. Molecular identification of an IP-linked mutation. (A) Pedigree of the IP-affected family being studied. Red and black circles denote carrier females; black squares denote nonaffected males; blue squares denote undiagnosed and deceased males; and red squares denote carrier and deceased males. (B) Genomic structure and organization of the human IKK gene (31). Coding and noncoding exons are shown in red and blue, respectively. G6PD, glucose-6-phosphate dehydrogenase. (C) Nucleotide (seq) and protein (prot) sequences of normal and mutant (IP) IKK alleles at the region of the mutation. The nucleotide sequence shows a 13-base duplication following a cytosine tract found in the IP-affected patient. The protein sequence shows the addition of four novel amino acids after proline 393 of human IKK, which results in a truncated protein that lacks all of the putative Zn finger. (D) Sequence of the putative Zn finger.

The IKK Zn finger is not required for assembly of the IKK complex. In a previous study, we were unable to detect IKK expression by immunoblot analysis of two primary fibroblast cultures that carry the IP mutation described above. These cultures were established from an aborted male fetus as well as a newborn male who died at birth, both of which were delivered by the same IP-affected mother (17). To find the reason for the inability to detect expression of the variant IP IKK polypeptides, we mapped the epitope recognized by the anti-IKK MAb (c73-1794) used in the previous study. We found that this particular MAb recognizes an epitope located within the putative Zn finger (data not shown). When we repeated the analysis with two other, more recently generated anti-IKK antibodies, we found reduced amounts of variant IKK polypeptides with sizes smaller than those of WT polypeptides (Fig. 2A). Using Northern blot analysis, we were unable to detect IKK mRNA expression in these IP fibroblasts (17), but the use of more sensitive reverse transcription-PCR analysis allowed the detection of reduced amounts of IKK transcripts in these IP fibroblasts (data not shown). We assume that the mutant mRNA is destabilized as a result of nonsense-mediated decay.

View larger version (34K): [in this window] [in a new window]

FIG. 2. Characterization of the variant IKK polypeptides encoded by the IP allele. (A) Reduced expression of truncated IKK polypeptides detected in IP fibroblasts. Whole-cell extracts from WT and IP fibroblasts were subject to immunoblot analysis with MAb c73-429 and rabbit polyclonal antibody 3294. (B) Interaction of WT- and IP-encoded IKK polypeptides with IKK and IKKß. Extracts of WT and IP male fibroblasts were immunoprecipitated with control immunoglobulin G (lane 1) or the following antibodies: MAb IMG-324 (lane 2), MAb c73-1794 (lane 3), MAb c73-429 (lane 4), MAb c73-764 (lane 5), and polyclonal antibody 3294 (lane 6), all against IKK; anti-IKK antibody M-280 (lane 7); and MAb B78-1 against IKK (lane 8). The samples were then probed with antibodies against IKK (IMG-136) and IKKß (MAb 10AG2; Upstate Biotechnology Inc.). As shown by the signals in lanes 7 and 8, the two extracts contained similar amounts of IKK and IKKß. (C) WT (top panel) and IP (bottom panel) cell lysates were chromatographed on a Superose 6 gel filtration column. The levels of the different IKK subunits present in each fraction were determined by immunoblotting with anti-IKK (MAb IMG-136) and anti-IKK (MAb c73-1794). Positions at which molecular weight markers (in thousands) eluted from this column are indicated. Inp, input.

We next examined whether IKK and IKKß can still physically interact with the mutant IKK polypeptides. Immunoblot analysis indicated that precipitation of the mutant IKK polypeptides with different antibodies brought down both IKK and IKKß (Fig. 2B). However, immunoprecipitation with anti-IKK MAb c73-1794 and MAb IMG-324, both of which are directed against the putative Zn finger, did not result in the isolation of either IKK or IKKß from the IP fibroblasts (Fig. 2B, lanes 2 and 3). To compare the sizes of the WT and mutant IKK complexes, cell lysates from WT and IP fibroblasts were prepared and separated by gel filtration on a Superose 6 column. IKK usually elutes from this column as two major species, a large one of approximately 900 kDa and a smaller one of approximately 300 kDa (5, 38). Although IKK and IKKß, as well as IKK activity, are found in both species, TNF- stimulation elevates the activity of only the larger complex (38). Immunoblot analysis indicated that IKK, IKKß (data not shown), and IKK were present mostly in the larger complex in WT fibroblasts (Fig. 2C, top panels). However, only a portion of the total IKK and IKKß pools (approximately 50%) coeluted with the larger IKK complex in IP cell extracts (Fig. 2C, bottom panels). A considerable fraction of the IKK and IKKß catalytic subunits eluted at between 400 and 600 kDa in IP cell lysates (Fig. 2C and data not shown). This midsize complex, found only in IP cell extracts, did not contain any IKK polypeptides, all of which eluted with the larger IKK complex (Fig. 2C). Therefore, the putative Zn finger is not required for binding to IKK or IKKß or for generation of the high-molecular-weight cytokine-regulated IKK complex. However, in the absence of sufficient amounts of IKK polypeptides, IKK-free complexes containing IKK and IKKß did appear. Despite the large reduction in IKK expression, there was only a twofold reduction in the amounts of IKK and IKKß catalytic subunits eluting within the high-molecular-weight complex of IP cell lysates relative to WT cell lysates. These results suggest that there is an excess of IKK over IKK and IKKß in WT fibroblasts.

Effect of a C-terminal truncation on IKK activation. We next examined whether deletion of the IKK Zn finger affected IKK activation by the proinflammatory cytokines TNF- and IL-1. WT and IP fibroblasts were stimulated for 5 min with TNF- or IL-1. Increasing amounts of either TNF- or IL-1 resulted in a dose-dependent increase in IKK activity (Fig. 3A). The level of TNF-- or IL-1-stimulated IKK activity was higher in WT fibroblasts at the different concentrations tested (Fig. 3A). Next, we stimulated WT and IP fibroblasts with saturating doses (10 ng/ml) of TNF- or IL-1 and measured IKK activity at different times. In both cell lines, IKK activity peaked at 5 min following TNF- or IL-1 stimulation (Fig. 3B). Furthermore, NF-B DNA binding activity (Fig. 3C) and IB degradation (Fig. 3D) were induced in WT and IP fibroblasts by TNF- and IL-1. Surprisingly, despite the marked reductions in IKK expression and IKK activity, the differences in the levels of induced NF-B DNA binding activity between WT and IP fibroblasts were not very dramatic. Nevertheless, TNF--induced NF-B activity in IP fibroblasts was considerably lower than that in WT fibroblasts, whereas IL-1-induced NF-B activity was not as different between the two cell lines (Fig. 3C). Correspondingly, IB degradation in IP fibroblasts was slower after TNF- stimulation than after IL-1 stimulation (Fig. 3D). The expression of the p50 and p65 subunits of NF-B, however, was normal in both cell lines (Fig. 3D). These results suggest that the putative Zn finger of IKK is required for maximal IKK activation by either TNF- or IL-1. Based on the more sensitive mobility shift assay, the activation of NF-B by TNF- is more dependent on full IKK activity, which requires the IKK Zn finger, than is the response to IL-1.

View larger version (27K): [in this window] [in a new window]

FIG. 3. Analysis of IKK and NF-B activation in WT and IP fibroblasts. (A) WT and IP human male fibroblasts were treated or not treated with different doses (0.1, 1, and 10 ng/ml) of TNF- or IL-1 for 5 min. Cells were lysed, and IKK activity (KA) was measured by an immunocomplex kinase assay with an anti-IKK (M-280) and glutathione S-transferase-IB(1-54) as a substrate. The samples were separated by sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane, and autoradiographed. The membrane was reprobed (Blot: IKK) with MAb IMG-136 against IKK as a loading control. (B) Same as in panel A, except that cells were treated with saturating doses of TNF- (10 ng/ml) or IL-1 (10 ng/ml) for different times as indicated prior to the determination of kinase activity. (C) Induction of NF-B DNA binding activity in WT and IP fibroblasts treated as described above. Whole-cell extracts (10 µg per sample) were incubated with an NF-B probe. The same extracts were also incubated with an NF-1 probe used as a control. DNA binding activity was determined by EMSAs. (D) Western blot analysis of IB, p50, and p65 in whole-cell extracts prepared from WT and IP fibroblasts treated as described for panel B.

Characterization of IKK LZ and Zn finger amino acid substitutions. LZ and Zn finger motifs are known to mediate protein-protein interactions. To investigate the role of these motifs in IKK function, we substituted L315, L322, L326, L329, and L336 within the C-terminal LZ with proline residues and C389 and C393 within the base of the Zn finger with serine residues (Fig. 4A). We also replaced P360 and P363, within a proline-rich region that may be recognized by SH3 domains, with alanine residues (Fig. 4A). With the pBabePuro retroviral expression system, the various mutants were introduced into IKK-deficient 3T3 cells (17). None of the mutants and none of the WT IKK constructs contained N- or C-terminal epitope tags to avoid potential interference with IKK complex assembly or activation. The levels of expression of WT IKK and mutant IKK in the reconstituted cells were similar to those of endogenous IKK in WT MEFs, with the exception of mutant M6, which was expressed at slightly reduced levels (Fig. 4B). The levels of expression of IKK were similar in all the reconstituted cells (Fig. 4B, bottom panel). It was previously shown that IKK migrates as a doublet, with several other minor polypeptides, on denaturing polyacrylamide gels (17, 27). Disruption of the mouse Ikk locus eliminates all IKK isoforms (17). Interestingly, the M6 mutation (C389S and C393S) in the IKK Zn finger resulted in the expression of only the slower-migrating isoform (Fig. 4B). The cause for this difference is currently unknown. Consistent with an analysis of C-terminal truncation mutants (27) (see above), all of the different substitution mutants of IKK were able to bind both IKK and IKKß (Fig. 4C).

View larger version (32K): [in this window] [in a new window]

FIG. 4. Mutational analysis of the IKK C-terminal region. (A) Scheme showing the structural features of full-length IKK and the amino acid substitutions introduced into different functional motifs (C-C, coiled coil; H, -helical region; ZF, Zn finger; SH3, SH3 binding site). The mutantsgenerated were as follows: M1 (L315P), M2 (L322P), M3 (L326P), M4 (L329P), M5 (L336P), M6 (C389S and C393S), and M7 (P360A and P363A). (B) IKK-deficient MEFs were reconstituted with WT IKK or the different amino acid substitution mutants described in panel A. Levels of expression of IKK in the different reconstituted cells were similar to those found in WT MEFs (control) that were not infected by any retrovirus. The membrane was reprobed with MAb IMG-136 against IKK as a loading control (bottom panel). (C) Amino acid substitutions within the C-terminal region of IKK do not affect binding to IKK or IKKß. IKK was immunoprecipitated from reconstituted cells or WT fibroblasts with a polyclonal antibody directed against its N terminus followed by immunoblotting with antibodies against IKK and IKKß. The membrane was reprobed with a rabbit polyclonal antibody against IKK as a loading control (bottom panel).

We next assayed the IKK activity associated with the different mutants and its regulation by TNF- or IL-1. Whereas WT IKK and LZ mutants M1, M3, and M4 were able to reconstitute cytokine-responsive IKK activity, very little IKK activity was generated by LZ mutants M2 and M5 following TNF- or IL-1 stimulation (Fig. 5). This lower level of IKK activity was not due to a problem with the expression or folding of mutants M2 and M5, since they were both expressed at levels similar to that of WT IKK and were able to associate with both IKK and IKKß. These results suggest that the M2 and M5 mutations may affect the ability of IKK to interact with upstream activators not yet identified. Interestingly, a higher level of basal IKK activity was generated by Zn finger mutant M6 (Fig. 5). Whereas IL-1 further increased the IKK activity associated with mutant M6 to a level similar to that associated with WT IKK, TNF- elicited only a minor increase in the level of IKK activity (Fig. 5). The levels of NF-B DNA binding activity generated by the various mutants were proportional to their levels of IKK activity (data not shown).

View larger version (35K): [in this window] [in a new window]

FIG. 5. Effects of amino acid substitutions within the C-terminal region of IKK on IKK activation by TNF- or IL-1. IKK-deficient cells that were either mock infected or reconstituted with either WT or amino acid substitution mutants of IKK were left untreated or treated with either TNF- (10 ng/ml) or IL-1 (10 ng/ml). Immunocomplex kinase assays were performed on cells lysed at the indicated times as described in the legend to Fig. 3B. The membrane was reprobed with MAb IMG-136 against IKK as a loading control (data not shown).

NF-B activation protects cells from TNF--induced apoptosis (16). We previously suggested that increased sensitivity to TNF--induced apoptosis may underlie much of the pathology seen in IP-affected patients and Ikk^+/- mice (17). We therefore examined the sensitivities of the various reconstituted mouse fibroblast cell lines as well as WT and IP human fibroblasts to TNF--induced apoptosis. Both WT mouse and human fibroblasts were resistant to TNF--induced apoptosis, whereas Ikk^- mouse fibroblasts and human fibroblasts expressing the IP allele were highly sensitive (Fig. 6). The expression of an IKK mutant that restores close to a normal level of IKK activity, M1, conferred TNF- resistance to Ikk^- fibroblasts, whereas the expression of mutants that exhibit a defective response to TNF- failed to restore full TNF- resistance. Importantly, the expression of mutant M6, which restores a nearly normal level of IL-1-induced IKK activity but exhibits only a weak response to TNF- (Fig. 5), caused only a partial reduction in TNF- sensitivity (Fig. 6).

View larger version (19K): [in this window] [in a new window]

FIG. 6. Effects of amino acid substitutions within the C-terminal region of IKK on susceptibility to TNF--induced apoptosis. WT mouse fibroblasts or Ikk- fibroblasts that were either mock reconstituted or reconstituted with WT or C-terminal substitution mutants of IKK as well as WT and IP human fibroblasts were treated with TNF- (50 ng/ml). After a 24-h incubation period, cells were fixed, stained with 4',6'-diamidino-2-phenylindole (DAPI), and mounted with a coverslip. Values shown are percentages of apoptotic nuclei per field scored by using a fluorescence microscope; error bars indicate standard deviations.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Several lines of evidence indicate that the IKK complex is the key to NF-B activation by TNF-, IL-1, and most other stimuli (12). Mouse knockout studies have confirmed that IKKß is the major protein kinase required for IB phosphorylation and eventual degradation in response to proinflammatory cytokines (14, 15, 33). Although lacking catalytic activity, the regulatory subunit of the IKK complex, IKK, plays an even more critical role in IKK and NF-B activation. The N-terminal domain of IKK is required both for the binding of IKK and IKKß and their assembly into a high-molecular-weight complex essential for activation (18, 19, 27). C-terminal deletion mutants of IKK were found to be unable to support IKK activation, even though they can still promote IKK holoenzyme assembly (19, 27).

In this study, we biochemically characterized the effect of a mutation in the human IKK locus, which cosegregates over three generations with the IP disease phenotype, on IKK and NF-B activation by proinflammatory stimuli. This mutation generates truncated IKK polypeptides which lack the putative Zn finger located at the extreme C terminus. Although IKK activation by both TNF- and IL-1 is decreased by removal of the Zn finger, part of the reduction is simply due to the approximate 50% reduction in the level of the high-molecular-weight IKK complex caused by reduced IKK expression (Fig. 2). However, the reduction in TNF-- or IL-1-induced IKK activation exceeds 50%, suggesting that the Zn finger of IKK makes an important, although not essential, contribution to signaling. It also appears that despite the considerable decrease in IKK activation in IP fibroblasts (Fig. 3A), the reduction in NF-B activation is not as large and is mostly limited to the response to TNF- and not to IL-1 (Fig. 3C). These findings suggest that only a small amount of IKK activation is required for NF-B activation. In support of this notion, it was recently shown that caspase 3 mediates the proteolysis of IKKß, which eliminates its kinase activity. However, effective reduction of IKK activation and diminished NF-B activation, which sensitizes cells to TNF--induced apoptosis, require multiple treatments with TNF- (34). These results suggest the existence of excess or surplus IKK complexes in levels that exceed those that are required for NF-B activation. This excess IKK could be important for the protection of cells from TNF--induced apoptosis.

Although the analysis of the particular IP mutation that we have studied suggests that the Zn finger may not be essential for IKK activation, the identification of point mutations in EDA-ID-affected patients (6, 10, 39), one of which results in a substitution of a cysteine at the base of the Zn finger, suggests that this motif is of functional importance. Indeed, we found that substitutions of other cysteines at the base of the Zn finger of mouse IKK result in a mutant, M6, that has almost normal responsiveness to IL-1 but is defective in the response to TNF- (Fig. 5).

Several other findings of the present study highlight the importance of the C-terminal region of IKK. Using site-directed mutagenesis, we found that the LZ located within this region is not required for IKK complex assembly but is important for responsiveness to both TNF- and IL-1. These results are consistent with those of previous reports demonstrating the importance of the C-terminal region of IKK through the generation and analysis of large deletion mutants. As discussed above, mutations within the Zn finger also have an adverse effect on IKK activation. The EDA-ID-linked substitution affecting C417 in human IKK prevents NF-B activation and B-cell immunoglobulin class switching following CD40L stimulation (10). We found that substitutions of two other cysteines, C389 and C393, which oppose the equivalent of C417 (C410 in the mouse) at the base of the Zn finger (Fig. 1D), reduced the response to TNF- but had hardly any effect on the response to IL-1. These results suggest that the C terminus of IKK may contain distinct but overlapping interaction surfaces that are required for connecting the IKK complex to different upstream activators. Despite the nearly normal response of mutant M6 (C389S and C393S) of IKK to IL-1, these mutations fail to restore resistance to TNF--induced apoptosis when expressed in IKK-deficient fibroblasts. Notably, all the mutations in IKK which reduce NF-B activation by TNF- also result in increased sensitivity to TNF--induced apoptosis.

In a separate study, we found that the inhibition of TNF- signaling alleviates most, if not all, of the IP-like symptoms in Ikk^+/- mice (C. Makris, unpublished data). Thus, it is likely that the signaling pathway most critical to the genesis of IP is the TNF- signaling pathway and that the most important outcome of the disease-linked mutations affecting the C terminus of IKK is increased sensitivity to TNF--induced apoptosis.

 
We thank the IP-affected patient and her son for providing blood samples.

C.M. was supported by a postdoctoral fellowship from the Cancer Research Institute. This work was supported by grants from the National Institutes of Health (ES04151 and AI43477) and the California Cancer Research Program.

 
* Corresponding author. Mailing address: Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0636. Phone: (858) 534-1361. Fax: (858) 534-8158. E-mail: karinoffice{at}ucsd.edu.

Present address: Merck Frosst Centre for Therapeutic Research, Merck Frosst Canada & Co., Kirkland, Quebec, Canada H9H 3L1.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-B in preventing TNF- induced cell death. Science 274:782-784.[Abstract/Free Full Text]
2
2. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-B. Nature 376:167-169.[CrossRef][Medline]
3
3. Cao, Y., G. Bonizzi, T. Seagroves, Greten, F., R. Johnson, E. Schmidt, and M. Karin. 2001. IKK provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107:763-775.[CrossRef][Medline]
4
4. Delhase, M., and M. Karin. 1999. The IB kinase: a master regulator of NF-B, innate immunity and epidermal differentiation. Cold Spring Harbor Symp. Quant. Biol. 64:491-503.
5
5. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IB kinase that activates the transcription factor NF-B. Nature 388:548-554.[CrossRef][Medline]
6
6. Doffinger, R., A. Smahi, C. Bessia, F. Geissmann, J. Feinberg, A. Durandy, C. Bodemer, S. Kenwrick, S. Dupuis-Girod, S. Blanche, P. Wood, S. H. Rabia, D. J. Headon, P. A. Overbeek, F. Le Deist, S. M. Holland, K. Belani, D. S. Kumararatne, A. Fischer, R. Shapiro, M. E. Conley, E. Reimund, H. Kalhoff, M. Abinun, A. Munnich, A. Israel, G. Courtois, and J. L. Casanova. 2001. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-B signaling. Nat. Genet. 27:277-285.[CrossRef][Medline]
7
7. Ganguly, A., M. J. Rock, and D. J. Prockop. 1993. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc. Natl. Acad. Sci. USA 90:10325-10329.[Abstract/Free Full Text]
8
8. Hu, Y., V. Baud, M. Delhase, P. Zhang, T. Deerinck, M. Ellisman, R. Johnson, and M. Karin. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKK subunit of the IB kinase. Science 284:316-320.[Abstract/Free Full Text]
9
9. Hu, Y., V. Baud, T. Oga, K. Kim, Y. Kazuhiko, and M. Karin. 2001. IKK controls formation of the epidermis independently of NF-B via a differentiation inducing factor. Nature 410:710-714.[CrossRef][Medline]
10
10. Jain, A., C. A. Ma, S. Liu, M. Brown, J. Cohen, and W. Strober. 2001. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohidrotic ectodermal dysplasia. Nat. Immunol. 2:223-228.[CrossRef][Medline]
11
11. Jin, D. Y., and K. T. Jeang. 1999. Isolation of full-length cDNA and chromosomal localization of human NF-B modulator NEMO to Xq28. J. Biomed Sci. 6:115-120.[Medline]
12
12. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-B activity. Annu. Rev. Immunol. 18:621-663.[CrossRef][Medline]
13
13. Li, Q., Q. Lu, J. Y. Hwang, D. Büscher, K.-F. Lee, J. C. Izpsua-Belmonte, and I. M. Verma. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1322-1328.[Abstract/Free Full Text]
14
14. Li, Q., D. Van Antwerp, F. Mercurio, K.-F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IB kinase 2 gene. Science 284:321-325.[Abstract/Free Full Text]
15
15. Li, Z.-W., W. Chu, Y. Hu, M. Delhase, T. Deerinck, M. Ellisman, R. Johnson, and M. Karin. 1999. The IKKß subunit of IB kinase (IKK) is essential for NF-B activation and prevention of apoptosis. J. Exp. Med. 189:1839-1845.[Abstract/Free Full Text]
16
16. Liu, Z.-G., H. Hu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-B activation prevents cell death. Cell 87:565-576.[CrossRef][Medline]
17
17. Makris, C., V. L. Godfrey, G. Krähn-Senftleben, T. Takahashi, J. L. Roberts, T. Schwarz, L. Feng, R. S. Johnson, and M. Karin. 2000. Female mice heterozygote for IKK/NEMO deficiencies develop a genodermatosis similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 15:969-979.
18
18. May, M. J., F. D'Acquisto, L. A. Madge, J. Glockner, J. S. Pober, and S. Ghosh. 2000. Selective inhibition of NF-B activation by a peptide that blocks the interaction of NEMO with the IB kinase complex. Science 289:1550-1554.[Abstract/Free Full Text]
19
19. Mercurio, F., B. W. Murray, A. Shevchenko, B. L. Bennett, D. B. Young, J. W. Li, G. Pascual, A. Motiwala, H. Zhu, M. Mann, and A. M. Manning. 1999. IB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19:1526-1538.[Abstract/Free Full Text]
20
20. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IB kinases essential for NF-B activation. Science 278:860-866.[Abstract/Free Full Text]
21
21. Miller, B. S., and E. Zandi. 2001. Complete reconstitution of human IKK complex in yeast. Assessment of its stoichiometry and the role of IKK on the complex activity in the absence of stimulation. J. Biol. Chem. 276:36320-36326.[Abstract/Free Full Text]
22
22. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
23
23. Poyet, J. L., S. M. Srinivasula, J. H. Lin, T. Fernandes-Alnemri, S. Yamaoka, P. N. Tsichlis, and E. S. Alnemri. 2000. Activation of the IB kinases by RIP via IKK/NEMO-mediated oligomerization. J. Biol. Chem. 275:37966-37977.[Abstract/Free Full Text]
24
24. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IB kinase. Cell 90:373-383.[CrossRef][Medline]
25
25. Roberts, J. L., B. Morrow, C. Vega-Rich, C. M. Salafia, and H. M. Nitowsky. 1998. Incontinentia pigmenti in a newborn male infant with DNA confirmation. Am. J. Med. Genet. 75:159-163.[CrossRef][Medline]
26
26. Rothwarf, D. M., and M. Karin. 1999. The NF-B activation pathway: a paradigm in information transfer from membrane to nucleus. SciSTKE 1999:RE1. [Online.]www.stke.org/cgi/content/fullOC_sigtrans;1999/5/re1.
27
27. Rothwarf, D. M., E. Zandi, G. Natoli, and M. Karin. 1998. IKK is an essential regulatory subunit of the IB kinase complex. Nature 395:297-300.[CrossRef][Medline]
28
28. Rudolph, D., W. C. Yeh, A. Wakeham, B. Rudolph, D. Nallainathan, J. Potter, A. J. Elia, and T. W. Mak. 2000. Severe liver degeneration and lack of NF-B activation in NEMO/IKK-deficient mice. Genes Dev. 14:854-862.[Abstract/Free Full Text]
29
29. Schmidt-Supprian, M., W. Bloch, G. Courtois, K. Addicks, A. Israel, K. Rajewsky, and M. Pasparakis. 2000. NEMO/IKKg-deficient mice model incontinentia pigmenti. Mol. Cell 5:981-992.[CrossRef][Medline]
30
30. Senftleben, U., Y. Cao, G. Xiao, F. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S.-C. Sun, and M. Karin. 2001. Activation by IKK of a second, evolutionarily conserved, NF-B signaling pathway. Science 293:1495-1499.[Abstract/Free Full Text]
31
31. Smahi, A., G. Courtois, P. Vabres, S. Yamaoka, S. Heuertz, A. Munnich, A. Israël, N. S. Heiss, S. M. Klauck, P. Kioschis, S. Wiemann, A. Poustka, T. Esposito, T. Bardaro, F. Gianfrancesco, A. Ciccodicola, M. D'Urso, H. Woffendin, T. Jakins, D. Donnai, H. Stewart, S. J. Kenwrick, S. Aradhya, T. Yamagata, M. Levy, R. A. Lewis, et al. 2000. Genomic rearrangement in NEMO impairs NF-B activation and is a cause of incontinentia pigmenti. Nature 405:466-472.[CrossRef][Medline]
32
32. Takeda, K., O. Takeuchi, T. Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKK. Science 284:313-316.[Abstract/Free Full Text]
33
33. Tanaka, M., M. E. Fuentes, K. Yamaguchi, M. H. Durnin, S. A. Dalrymple, K. L. Hardy, and D. V. Goeddel. 1999. Embryonic lethality, liver degeneration, and impaired NF-B activation in IKKß-deficient mice. Immunity 10:421-429.[CrossRef][Medline]
34
34. Tang, G., J. Yang, Y. Minemoto, and A. Lin. 2001. Blocking caspase-3-mediated proteolysis of IKKß suppresses TNF-induced apoptosis. Mol. Cell 8:1005-1016.[CrossRef][Medline]
35
35. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-induced apoptosis by NF-B. Science 274:787-789.[Abstract/Free Full Text]
36
36. Wang, C.-Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-B. Science 274:784-787.[Abstract/Free Full Text]
37
37. Yamaoka, S., G. Courtois, C. Bessia, S. T. Whiteside, R. Weil, F. Agou, H. E. Kirk, R. J. Kay, and A. Israël. 1998. Complementation cloning of NEMO, a component of the IB kinase complex essential for NF-B activation. Cell 93:1231-1240.[CrossRef][Medline]
38
38. Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IB kinase complex (IKK) contains two kinase subunits, IKK and IKKß, necessary for IB phosphorylation and NF-B activation. Cell 91:243-252.[CrossRef][Medline]
39
39. Zonana, J., M. E. Elder, L. C. Schneider, S. J. Orlow, C. Moss, M. Golabi, S. K. Shapira, P. A. Farndon, D. W. Wara, S. A. Emmal, and B. M. Ferguson. 2000. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK (NEMO). Am. J. Hum. Genet. 67:1555-1562.[CrossRef][Medline]

---

Molecular and Cellular Biology, September 2002, p. 6573-6581, Vol. 22, No. 18
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.18.6573-6581.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Cordier, F., Grubisha, O., Traincard, F., Veron, M., Delepierre, M., Agou, F. (2009). The Zinc Finger of NEMO Is a Functional Ubiquitin-binding Domain. J. Biol. Chem. 284: 2902-2907 [Abstract] [Full Text]  
• Bloor, S., Ryzhakov, G., Wagner, S., Butler, P. J. G., Smith, D. L., Krumbach, R., Dikic, I., Randow, F. (2008). Signal processing by its coil zipper domain activates IKK{gamma}. Proc. Natl. Acad. Sci. USA 105: 1279-1284 [Abstract] [Full Text]  
• Souto-Carneiro, M. M., Fritsch, R., Sepulveda, N., Lagareiro, M. J., Morgado, N., Longo, N. S., Lipsky, P. E. (2008). The NF-{kappa}B Canonical Pathway Is Involved in the Control of the Exonucleolytic Processing of Coding Ends during V(D)J Recombination. J. Immunol. 180: 1040-1049 [Abstract] [Full Text]  
• Sebban-Benin, H., Pescatore, A., Fusco, F., Pascuale, V., Gautheron, J., Yamaoka, S., Moncla, A., Ursini, M. V., Courtois, G. (2007). Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Hum Mol Genet 16: 2805-2815 [Abstract] [Full Text]  
• Solt, L. A., Madge, L. A., Orange, J. S., May, M. J. (2007). Interleukin-1-induced NF-{kappa}B Activation Is NEMO-dependent but Does Not Require IKKbeta. J. Biol. Chem. 282: 8724-8733 [Abstract] [Full Text]  
• Kaileh, M., Vanden Berghe, W., Heyerick, A., Horion, J., Piette, J., Libert, C., De Keukeleire, D., Essawi, T., Haegeman, G. (2007). Withaferin A Strongly Elicits I{kappa}B Kinase beta Hyperphosphorylation Concomitant with Potent Inhibition of Its Kinase Activity. J. Biol. Chem. 282: 4253-4264 [Abstract] [Full Text]  
• Wicovsky, A., Muller, N., Daryab, N., Marienfeld, R., Kneitz, C., Kavuri, S., Leverkus, M., Baumann, B., Wajant, H. (2007). Sustained JNK Activation in Response to Tumor Necrosis Factor Is Mediated by Caspases in a Cell Type-specific Manner. J. Biol. Chem. 282: 2174-2183 [Abstract] [Full Text]  
• Park, K. A., Byun, H. S., Won, M., Yang, K.-J., Shin, S., Piao, L., Kim, J. M., Yoon, W.-H., Junn, E., Park, J., Seok, J. H., Hur, G. M. (2007). Sustained activation of protein kinase C downregulates nuclear factor-{kappa}B signaling by dissociation of IKK-{gamma} and Hsp90 complex in human colonic epithelial cells. Carcinogenesis 28: 71-80 [Abstract] [Full Text]  
• Vinolo, E., Sebban, H., Chaffotte, A., Israel, A., Courtois, G., Veron, M., Agou, F. (2006). A Point Mutation in NEMO Associated with Anhidrotic Ectodermal Dysplasia with Immunodeficiency Pathology Results in Destabilization of the Oligomer and Reduces Lipopolysaccharide- and Tumor Necrosis Factor-mediated NF-{kappa}B Activation. J. Biol. Chem. 281: 6334-6348 [Abstract] [Full Text]  
• Kim, S.-W., Hayashi, M., Lo, J.-F., Fearns, C., Xiang, R., Lazennec, G., Yang, Y., Lee, J.-D. (2005). Tid1 Negatively Regulates the Migratory Potential of Cancer Cells by Inhibiting the Production of Interleukin-8. Cancer Res. 65: 8784-8791 [Abstract] [Full Text]  
• Ear, T., Cloutier, A., McDonald, P. P. (2005). Constitutive Nuclear Expression of the I{kappa}B Kinase Complex and Its Activation in Human Neutrophils. J. Immunol. 175: 1834-1842 [Abstract] [Full Text]  
• Hayden, M. S., Ghosh, S. (2004). Signaling to NF-{kappa}B. Genes Dev. 18: 2195-2224 [Abstract] [Full Text]  
• Agou, F., Traincard, F., Vinolo, E., Courtois, G., Yamaoka, S., Israel, A., Veron, M. (2004). The Trimerization Domain of Nemo Is Composed of the Interacting C-terminal CC2 and LZ Coiled-coil Subdomains. J. Biol. Chem. 279: 27861-27869 [Abstract] [Full Text]  
• Ran, R., Lu, A., Zhang, L., Tang, Y., Zhu, H., Xu, H., Feng, Y., Han, C., Zhou, G., Rigby, A. C., Sharp, F. R. (2004). Hsp70 promotes TNF-mediated apoptosis by binding IKK{gamma} and impairing NF-{kappa}B survival signaling. Genes Dev. 18: 1466-1481 [Abstract] [Full Text]  
• Yang, F., Yamashita, J., Tang, E., Wang, H.-l., Guan, K., Wang, C.-Y. (2004). The Zinc Finger Mutation C417R of I-{kappa}B Kinase {gamma} Impairs Lipopolysaccharide- and TNF-Mediated NF-{kappa}B Activation through Inhibiting Phosphorylation of the I-{kappa}B Kinase {beta} Activation Loop. J. Immunol. 172: 2446-2452 [Abstract] [Full Text]  
• Tang, E. D., Wang, C.-Y., Xiong, Y., Guan, K.-L. (2003). A Role for NF-{kappa}B Essential Modifier/I{kappa}B Kinase-{gamma} (NEMO/IKK{gamma}) Ubiquitination in the Activation of the I{kappa}B Kinase Complex by Tumor Necrosis Factor-{alpha}. J. Biol. Chem. 278: 37297-37305 [Abstract] [Full Text]  
• Saitoh, T., Nakayama, M., Nakano, H., Yagita, H., Yamamoto, N., Yamaoka, S. (2003). TWEAK Induces NF-{kappa}B2 p100 Processing and Long Lasting NF-{kappa}B Activation. J. Biol. Chem. 278: 36005-36012 [Abstract] [Full Text]  
• Carter, R. S., Pennington, K. N., Ungurait, B. J., Ballard, D. W. (2003). In Vivo Identification of Inducible Phosphoacceptors in the IKK{gamma}/NEMO Subunit of Human I{kappa}B Kinase. J. Biol. Chem. 278: 19642-19648 [Abstract] [Full Text]  
• Tegethoff, S., Behlke, J., Scheidereit, C. (2003). Tetrameric Oligomerization of I{kappa}B Kinase {gamma} (IKK{gamma}) Is Obligatory for IKK Complex Activity and NF-{kappa}B Activation. Mol. Cell. Biol. 23: 2029-2041 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Makris, C. Articles by Karin, M. Search for Related Content PubMed PubMed Citation Articles by Makris, C. Articles by Karin, M.